$RMD News

Unlocking Q1 Potential of ResMed (RMD): Exploring Wall Street Estimates for Key Metrics

ResMed (RMD) Q3 earnings report preview: what to look for

Will ResMed (RMD) Beat Estimates Again in Its Next Earnings Report?

ResMed Set to Report Q1 Earnings: What's in the Cards for the Stock?

Learn Why The Bull Case For ResMed (RMD) Could Change Following U.S. Mask Launch

ResMed (RMD) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Resmed Launches AirTouch™ F40 Full Face Fabric CPAP Mask in the U.S.

ResMed’s Quarterly Earnings Preview: What You Need to Know

ResMed Q4 2026 Earnings Call Transcript

ResMed (NYSE:RMD) Offers Dividend Investors a Sustainable Payout Built on Quality Fundamentals

ResMed (RMD): Buy, Sell, or Hold Post Q2 Earnings?

Resmed to Report First Quarter Fiscal 2027 Earnings on October 29, 2026

ResMed Inc. (RMD)’s Sleep Apnea Leadership Supports Growth Despite Rising Competitive Pressures

Sleep Device Maker ResMed Gets an Upgrade. Analysts See a Lot to Like.

This Analyst Just Upgraded ResMed Stock. Here's Why.

RBC Capital Upgrades ResMed to Outperform from Sector Perform

Is Margin Pressure From Rising Costs Altering The Investment Case For ResMed (RMD)?

ResMed Projected to Attain High-Single-Digit EPS Growth in Next Three Years, RBC Says

ResMed Inc. (RMD) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

RBC Capital Upgrades ResMed to Outperform, Raises Price Target to $262